TIFFANY JONES: Open Payments
NPI 1659700136 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,339 in 61 payments from 18 companies in 2025. Trend: 2023 $22,401 · 2024 $25,006 · 2025 $13,339
Speaker / faculty: $9,520Consulting: $1,540Food & beverage: $1,257Travel & lodging: $1,022
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $9,558 |
| E.R. Squibb & Sons, L.L.C. | 11 | $2,839 |
| Novartis Pharmaceuticals Corporation | 9 | $161 |
| ABBVIE INC. | 4 | $115 |
| Pharmacosmos Therapeutics Inc. | 1 | $108 |
| Gilead Sciences, Inc. | 5 | $105 |
| Tempus AI, Inc | 1 | $95 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| PFIZER INC. | 3 | $55 |
| Daiichi Sankyo Inc. | 2 | $42 |
Products named: IMFINZI, TAGRISSO, OPDIVO, MONOFERRIC, KISQALI, XT CDX, IMBRUVICA, KEYTRUDA.
Industry payments across OH — which companies pay providers there.
